Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 6 papers. Top paper: “Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: a multicentre, single-arm, phase 2 trial”.
Anthony R Mato, Ahmet Dogan, Venkatraman E Seshan, Erel Joffe, Kelsey Flaherty +41 more
Yu-Huan Shih, Lwaki Ebarasi, Ann S. Grosse, Daneal Portman, Ayano Chiba +8 more
Daneal Portman, Feston Idrizi, Ann S. Grosse, Nathan D. Lawson, Yu-Huan Shih
Yu-Huan Shih, Lwaki Ebarasi, Ann S. Grosse, Daneal Portman, Ayano Chiba +8 more
Daneal Portman, Feston Idrizi, Ann S. Grosse, Nathan D. Lawson, Yu-Huan Shih
Huimin Yin, Yu-Huan Shih, Takayuki Nozaki, Daneal Portman, Benjamin J. Toles +11 more